Company Filing History:
Years Active: 2022
Title: Innovator Spotlight: Shin-Ae Kim and His Breakthrough in Pharmaceutical Composition
Introduction: Shin-Ae Kim, a prominent inventor based in Daegu, South Korea, has made significant strides in the field of pharmaceuticals. With a focus on innovative compositions aimed at addressing critical health issues, he holds a patent that showcases his commitment to advancing medical science.
Latest Patents: Kim's notable patent, titled "2-cyanopyrimidin-4-yl carbamate or urea derivative or salt thereof, and pharmaceutical composition including same," presents a groundbreaking approach in the treatment of osteoporosis. This invention includes a 2-cyanopyrimidin-4-yl carbamate or urea derivative, as well as processes for its preparation. The pharmaceutical composition derived from this invention selectively inhibits cathepsin K, promising significant benefits for individuals at risk of osteoporosis.
Career Highlights: As an innovator at Hanlim Pharmaceutical Co., Ltd., Shin-Ae Kim has leveraged his expertise to contribute to the development of therapeutic solutions for pressing health concerns. His dedication to research and innovation is a driving force behind his successful patent application.
Collaborations: Kim works alongside talented colleagues, including Kyung-Hee Kim and Jung-Wook Chin. Together, they foster a collaborative environment at Hanlim Pharmaceutical, enhancing the company’s research capabilities and fostering innovation in pharmaceutical development.
Conclusion: Shin-Ae Kim stands out as a dedicated inventor in the pharmaceutical sector. His innovative work reflects his passion for addressing health-related challenges through science. With his patent on the 2-cyanopyrimidin-4-yl derivative, Kim continues to pave the way for advancements in treatments aimed at improving the quality of life for many individuals facing osteoporosis.